Electrochemically Driven Strategies Enabling the Construction of Carbon–Carbon/Carbon–Heteroatom Bonds
Synlett · 01.12.2025 · 36 (20) · 3294-3308
DOI: 10.1055/a-2675-4286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synlett, erschienen am 01.12.2025. Verfasst von Anil Balajirao Dapkekar und 1 weiteren Autor:innen. Die Arbeit nennt 71 Literaturangaben.
Abstract (Originalsprache)
The scientific community has recently shown a significant interest in electro-organic synthesis, which has been recognized as a promising, environmentally friendly, and sustainable tool for organic synthesis. Here, the electric current acts as a reagent to drive chemical transformations, which avoids the usage of hazardous, oxidizing, and reducing reagents. Therefore, herein, we present an account of recent developments in electrochemical synthetic methodologies that were developed in our laboratory, such as the synthesis of tertiary alcohols, 3-selenylindoles, sulfenyl-phenanthrenes, spiro-cyclohexadienone indenes, β-hydroxy-selenides, 4-sulfenyl-isochromenones, and para-hydroxysulfonamides/acetanilides. We hope this account will provide the feasibility for and further advancements in reaction design, mechanistic understanding, and the pertinence of electro-catalysis in academic and industry frameworks.
Zitieren
APA
Dapkekar, A. B., & Satyanarayana, G. (2025). Electrochemically Driven Strategies Enabling the Construction of Carbon–Carbon/Carbon–Heteroatom Bonds. Synlett, 36(20), 3294-3308. https://doi.org/10.1055/a-2675-4286
Vancouver
Dapkekar AB, Satyanarayana G. Electrochemically Driven Strategies Enabling the Construction of Carbon–Carbon/Carbon–Heteroatom Bonds. Synlett. 2025;36(20):3294-3308. doi:10.1055/a-2675-4286
BibTeX
@article{Dapkekar2025,
author = {Dapkekar, Anil Balajirao and Satyanarayana, Gedu},
title = {Electrochemically Driven Strategies Enabling the Construction of Carbon–Carbon/Carbon–Heteroatom Bonds},
journal = {Synlett},
year = {2025},
volume = {36},
number = {20},
pages = {3294--3308},
doi = {10.1055/a-2675-4286}
}
EUVIMED